We know cannabis has powerful potential medical effects. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine. Click Here to Watch Thank you @Harri Leigh of @WPMT FOX43 for highlighting our work.
The transition from medical marijuana to cannabis-based pharmaceutical drugs | Little Green Pill
PUBLISHED Mar 02, 2022
Suggested reads
Mar 31, 2022
Groff North America partners with Pennsylvania college for first-of-its-kind cannabinoid major
FOR IMMEDIATE RELEASE
CONTACT: Amanda Peterson Martin
apmartin@gavinadv.com
484-949-1320
Groff North America partners with Pennsylvania college for first
Read more
Mar 04, 2022
How will Groff North America cannabis products be developed from research to market as medicines?
How will Groff North America cannabis products be developed from research to market as medicines? CEO Joe Gryzb talked to Harri Leigh of WPMT FOX43 about the potenti
Read more
Mar 03, 2022
We are making history at Groff North America!
We are making history at Groff North America. After 53 years, we are one of five companies approved to grow and study cannabis for medical research in the U.S. WPMT
Read more
Feb 23, 2022
Groff North America makes historic cannabis transaction with DEA
FOR IMMEDIATE RELEASE
CONTACT: Jay Scott
jscott@gavinadv.com
484-695-3774
Groff North America makes historic cannabis transactio
Read more